News
03-22-2012, 01:08 AM
ONCOLOGY Promise of new treatment options for chemotherapy-resistant breast cancers p53 is lost or functionally impaired in many human cancers, and its absence is often associated with a poor response to conventional chemotherapy. Thus, much effort is currently devoted to developing novel treatments for p53-deficient malignancies...
More... (http://www.medicalnewstoday.com/releases/243173.php)
More... (http://www.medicalnewstoday.com/releases/243173.php)